Inveas Pharma Private Limited - Company Profile

It is a pharma private limited company based in Banjarahills, Telangana, India, established in 2021.
2021 Banjarahills, Telangana, India Active
Last Updated:
Access Report
About Inveas Pharma Private Limited

Inveas Pharma Private Limited, a active private limited company, was established on 30 November 2021 in Banjarahills, Telangana, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U51397TG2021PTC157478. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Beeravalli Vijayabhaskara Reddy (Director), Brahma Reddy Prathi (Director), Venkateswara Rao Karanam (Director). It is based at F No 205, Road No 12,, Banjarahills, Telangana, 500034.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51397TG2021PTC157478

  • Registration Number

    157478

  • Incorporation Date

    30 November 2021

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 4 Year, 2 Months
Company report

Inveas Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Inveas Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Inveas Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Beeravalli Vijayabhaskara Reddy Director 30 Nov 2021 Current
Brahma Reddy Prathi Director 30 Nov 2021 Current
Venkateswara Rao Karanam Director 30 Nov 2021 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Inveas Pharma.

Enhance accessibility to Inveas Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Inveas Pharma revenue growth over time
Inveas Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Inveas Pharma?

Unlock access to Inveas Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Inveas Pharma?

Inveas Pharma has a workforce of 0 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Inveas Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inveas Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Inveas Pharma
Recent Activity within the Organization
  • Director Appointment

    The activity Beeravalli Vijayabhaskara Reddy was appointed as a Director was appointed as a Director on 30 Nov 2021 & has been associated with this company since 4 years 2 months . was completed.

  • Director Appointment

    The activity Brahma Reddy Prathi was appointed as a Director was appointed as a Director on 30 Nov 2021 & has been associated with this company since 4 years 2 months . was completed.

  • Director Appointment

    Venkateswara Rao Karanam was appointed as a Director was appointed as a Director on 30 Nov 2021 & has been associated with this company since 4 years 2 months . was recorded as a recent event.

  • Company Incorporation

    The activity Inveas Pharma Private Limited was registered on 30 Nov 2021 with Roc Hyderabad & aged 4 years 2 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Inveas Pharma Private Limited?

The CIN of Inveas Pharma Private Limited is U51397TG2021PTC157478.

Where is Inveas Pharma Private Limited headquartered?

Inveas Pharma Private Limited is headquartered at F No 205, Road No 12,, Banjarahills, Telangana, 500034.

When was Inveas Pharma Private Limited incorporated?

Inveas Pharma Private Limited was incorporated on 30 November 2021.

Who are the current directors of Inveas Pharma Private Limited?

The current directors of Inveas Pharma Private Limited are

What is the primary industry of Inveas Pharma Private Limited?

The primary industry of Inveas Pharma Private Limited is Pharma.

Is Inveas Pharma Private Limited a listed company?

Inveas Pharma Private Limited is unlisted.

What is the capital structure of Inveas Pharma Private Limited?

The authorized capital of Inveas Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available